Ceftobiprole

Shenzhen China Resources Gosun Pharmaceutical Co. granted exclusive license to develop, manufacture and to commercialize Basilea’s antibiotic Zevtera® (ceftobiprole) in China, Hong Kong and Macau

BASEL, 02-Oct-2017 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Basilea Pharmaceutica International Ltd. (Basilea) has entered into…

7 years ago

Basilea announced improved operating results in its H1-2013 financials

Continued improvement in financial performance Cash and short-term investments of CHF 262.8 million Guidance on isavuconazole phase 3 topline data…

11 years ago